HIV shedding in cervico-vaginal secretions in pregnant women

Current HIV Research

Volumn 9, Issue 5, 2011, Pages 313-320

  Gardella, Barbara ^a   Roccio, Marianna ^a   Maccabruni, Anna ^a   Mariani, Bianca ^a   Panzeri, Lucia ^a   Zara, Francesca ^b   Spinillo, Arsenio ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cervico vaginal secretions; HIV shedding; Nucleic acids; Vertical transmission

Indexed keywords

VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; VAGINA SECRETION; VIRUS SHEDDING;

ADULT; CERVIX UTERI; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VAGINA; VIRUS SHEDDING;

EID: 80053941674     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/157016211797636017     Document Type: Article

References (42)

1. RCOG 2005, BJOG: an International Journal of Obstet and Gynecol. Preventing mother-to-child transmission of HIV: successes and challenges. Review. 112: 1196-1203.
2. Newell ML. Mechanism and timing of mother-to-child transmission of HIV1. AIDS 1998; 12: 831-837.
3. Gaillard P. Exposure to HIV-1 during delivery and mother-to-child transmission. AIDS 2000, 14: 2341-2348.
4. International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: a meta-analysis of 15 prospective cohort studies. N Engl J Med 1999; 340: 977-987.
5. European mode of delivery Collaboration. Elective caesareansection versus vaginal delivery in prevention of vertical HIV transmission: a randomized clinical trial. Lancet 1999; 353: 1035-1039.
6. Jamieson JD, Read JS, Kourtis A: Cesarean delivery for HIVinfected women: recommendations and controversies. AJOG Sept 2007: S96-100.
7. RCOG Green- top Guideline n. 39: Management of HIV in pregnancy. June 2010: 1-28.
8. Warszawski J, Tubiana R, Le Chenadec J. Mother-to-child HIV transmission despite antiretroviral therapyin the ANRS French Perinatal cohort. AIDS 2008; 22: 289-299.
9. Towsend CL, Cortina-Borja M, Peckham CS et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in United Kingdom and Ireland, 2000-2006. AIDS 2008; 22: 973-981.
10. Floridia M, Ravizza M, et al. Italian Group on surveillance on antiretroviral treatment in pregnancy. Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy. Epidemiol Infect 2006; 134: 1120-1127.
11. De Biaggi M, Spinillo A, Zara F, De Santolo A, et al. Quantitative assessment of cell-associated and cell-free virus in cervico-vaginal samples of HIV-1- infected women. Clin microbiol Infect 1999; 5: 605-611.
12. Ehrlich GD. PCR-based methods for the detection of the human retriviridae and Hepnadnaviridae. In: Erlich GD, Greenberg SJ, editors. PCR-based diagnostics in infectious disease. Boston (Mass): Blacwell Scientific Publications; 1994, p 415-446.
13. Menzo S, Bagnarelli P, Giacca M, et al. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse trascription and polymerase chain reaction. J Clin Microbiol 1992; 30: 1752-1757.
14. Kovacs A, Wasserman S, Burns D, et al. Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001; 358: 1593-1601.
15. De Biaggi, Zara F, Spinillo A, et al. Viral excretion in cervico secretions of HIV-1 infected women receiving antiretroviral therapy. Eur J Clin Microb Infect Dis 2001; 20: 91-96.
16. Hart CE, Lennox JL, Pratt-Palmore M, et al. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis 1999; 179: 871-882.
17. Cu-Uvin S, De Long AK, Venkatesh KK, et al. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. AIDS 2010; 24(16): 2489-2497.
18. Spinillo A, De Biaggi M, Zara F, et al. Human Immunodeficiency virus type 1- related nucleic acids and papillomavirus DNA in cervico-vaginal secretions of immunodeficiency virus-infected women. Obstet Gynec 2001; 97: 999-1004.
19. De Pasquale MP, Leigh Brown AJ, Uvin SC, et al. Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy. JAIDS 2003; 34(1): 37-44.
20. Philpott S, Burger H, Tsoukas C, et al. Human immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination. J Virol 2005; 79 (1): 353-363.
21. Chaudhary S, Noel RJ, Rodríguez N, et al. Correlation between CD4 T cell counts and virus compartmentalization in genital and systemic compartments of HIV-infected females. Virol 2011, 9 Jul. [Epub ahead of print].
22. Chia C Wang, Scott Mc Clelland R, Overbaugh J, et al. The effect of hormonal contraception on genital tract shedding of the HIV -1. AIDS 2004; 18 (2): 205-9.
23. John GC, Nduati RW, Mbori-Ngacha D, et al. Genital shedding of HIV-1 DNA during pregnancy: association with immunodepression, abnormal cervical or vaginal discharge and severe vitamine A deficiency. J Infect Disease 1997; 175: 57-62.
24. Zdenek Hel et al. Sex steroid hormones, hormonal contraception and the immunobiology of HIV infection. Endocrine Rev 2010; 31: 79-97.
25. Benki S, Mostaf S, Richardson B, et al. Cyclic shedding of HIV -1 RNA in cervical secretions during the menstrual cycle. J Infect Dis 2004; 189: 2192-2201.
26. Kolesnittchenko V, Suart RS. Regulatory elements in the human immunodeficiency virus type 1 long terminal repeat LTR (HIV-1) responsive to steroid hormon stimulation. AIDS Res Human Retrovir 1992; 8: 1977-1978.
27. Grossman CJ. Regulation of the Immune System by sex steroids. Endocrine Rev 1984; 5: 435-455.
28. Coleman JS, Hitti J, Bukusi EA, et al. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 2007; 21: 755-759.
29. Spinillo A, Debiaggi M, Zara F, et al. Factors associated with nucleic acid related to human immunodeficiency virus type 1 in cervico-vaginal secretions. BJOG 2001; 108: 634-641.
30. Cu-Uvin S, Hogan JW, Caliendo AM, et al. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 2001; 33(6): 894-896.
31. Johnson BT, Scott-Sheldon LA, et al. Intervention to reduce sexual risk for Human Immunodeficiency virus among adolescents. A meta-analysis of trials, 1985-2008. Arch Pediatric Adolesc Med 2011; (165)1: 77-84.
32. Weller SC, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002; (1): CD003255.
33. Mostad S, Overbaugh J, De Vange D, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997; 350: 922-7.
34. Baeten JM, Lavreys L, Overbaugh J. The influence of hormonal contraceptive use on HIV-1 trasmission and disease progression. Clin Infect Dis 2007; 45: 360-9.
35. Wang CC, reilly M, Kreiss JK. Risk of HIV infection in oral contraceptive users: a meta-analysis. J Acquir IMMUNe Defic Syndr 1999; 21: 51-8.
36. Coombs RW, Speck CE, Hughes JP, et al. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV rna levels in semen and in blood: evidence for compartimentalization of HIV -1 between semen and blood. J Infect Dis 1998; 177: 320-30.
37. Graham SM, Holte SE, Pesuv NM, et al. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV 1 shedding. AIDS 2007; 21 (4): 501-7.
38. Tubiana R, Le Chenadec J, Rousioux C, et al. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load < 500 copies/mL at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1). Clin Infect Dis 2010; 50: 585-596.
39. European Collaborative Study. Mother-to-child trasmission of HIV infection in the era of higly active antiretroviral therapy. Clin Infect Dis 2005; 40: 458-465.
40. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of trasmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996; 335: 1621-9.
41. American College of Obstetricians and Gynecologist. Scheduled cesarean delivery and the prevention of vertical trasmission of HIV infection: ACOG committee opinion no. 219: Committee on Obstetrc Practice. Int J Gynecol Obstet 1999; 66: 305-6.
42. Chuachoowang R, Shaffer N, Siriwasin W, et al. Short-course of antenatal zidovudine reduces both cervico-vaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal trasmission. J Infect Dis 2000; 181: 99-106.